Nicotinamide riboside
Content by: OpenSupplement Editorial Team | Medical review: pending | Last updated: April 13, 2026
TL;DR
Premium vitamin B3 form that effectively raises NAD+ levels without niacin flush
Martens trial confirmed significant NAD+ elevation in healthy middle-aged adults [1]
Works by providing direct NAD+ precursor, bypassing metabolic bottlenecks of regular niacin
Well-tolerated up to 2000 mg daily with minimal side effects in studies
Monthly cost $70-120 for effective dosing — among the most expensive supplements
Best for: experimental anti-aging, NAD+ optimization enthusiasts
What it is
Nicotinamide riboside (NR) is a form of vitamin B3 that serves as a direct precursor to NAD+ (nicotinamide adenine dinucleotide), a crucial coenzyme involved in cellular energy production and DNA repair. Unlike regular niacin, NR raises NAD+ levels efficiently without causing the uncomfortable flushing reaction that limits niacin supplementation.
NAD+ levels decline significantly with aging — dropping by roughly 50% between ages 40 and 60 — leading to the hypothesis that restoring NAD+ might slow aging processes. NR bypasses the metabolic limitations that prevent other B3 forms from effectively raising NAD+, making it the most efficient NAD+ precursor available as a supplement. However, the critical question remains whether raising NAD+ through supplementation actually translates to the health benefits observed when NAD+ is naturally high.
What the research says
NAD+ elevation confirmed — The Martens study [1] definitively showed that NR supplementation raises NAD+ levels in healthy middle-aged and older adults. This biomarker success provides the foundation for cognitive benefit claims, but actual cognitive outcomes weren't measured in this trial.
Translation gap remains — While NAD+ is crucial for neuronal energy production and DNA repair, no published studies have demonstrated that NR supplementation improves cognitive function or slows cognitive decline in humans. Several trials are ongoing, but current evidence remains at the biomarker level rather than functional outcomes.
Industry bias concerns — Much NR research is funded by ChromaDex, which holds key patents on the compound. While this doesn't invalidate the science, it adds bias concerns that independent replication would help resolve.
Current recommendation: NR remains experimental for cognitive benefits. The NAD+ elevation is real and the mechanism compelling, but functional cognitive benefits await proper clinical validation.
Compelling aging rationale — Cardiovascular NAD+ levels decline with age, and low NAD+ is associated with endothelial dysfunction and reduced cardiac energy metabolism. The Martens study [1] confirmed NR raises NAD+ in middle-aged adults, potentially addressing this age-related decline.
No cardiovascular endpoints studied — Despite the strong theoretical rationale, no published studies have examined NR's effects on blood pressure, arterial stiffness, cardiac function, or cardiovascular disease outcomes in humans.
Current recommendation: NR remains speculative for cardiovascular health. While the NAD+ decline hypothesis is compelling and biomarker elevation confirmed, established cardioprotective interventions have far stronger evidence bases for heart health.
Mitochondrial function improvements — The Elhassan study [2] showed that NR supplementation improved mitochondrial-related gene expression and reduced inflammatory markers in skeletal muscle tissue. The Dellinger trial [3] demonstrated sustained NAD+ elevation over multiple weeks, suggesting the biomarker effects persist.
Biomarkers vs. outcomes — While these studies show promising changes in mitochondrial function markers, they haven't translated to measurable improvements in metabolic health outcomes like glucose control, insulin sensitivity, or cardiovascular risk factors.
Current assessment: The mechanistic rationale for metabolic benefits is strong, and early biomarker data is encouraging. However, NR remains unproven for actual metabolic syndrome treatment or prevention pending studies that measure clinical endpoints rather than just biomarkers.
DISCLAIMER: The information on this page is for educational purposes only and has not been evaluated by the Food and Drug Administration. This content is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before using any dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.
This page may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. Learn more.
Nicotinamide riboside on Amazon
Safety
Nicotinamide riboside demonstrates good tolerability in human studies, with doses up to 2000 mg daily showing no significant adverse effects in the available trials. Some users report mild nausea at higher doses, but this appears uncommon and dose-dependent.
Long-term safety data remains limited given NR's recent commercial availability. Theoretical concerns exist about NAD+ elevation potentially supporting cancer cell metabolism, but no clinical evidence supports this worry and it remains speculative.
Interactions
• No significant documented drug interactions in clinical literature • Other NAD+ precursors — May have additive effects with NMN or niacin, though combination studies lacking • Chemotherapy agents — Theoretical concern about NAD+ supporting cancer cell metabolism, but no clinical data • Blood pressure medications — No documented interactions, but cardiovascular effects of NAD+ elevation unstudied • Diabetes medications — No known interactions, though metabolic effects theoretically possible
Dosing
Standard anti-aging dose: 300-1000 mg daily, typically taken as a single morning dose. The Martens study [1] used 1000 mg daily with good NAD+ elevation.
Higher experimental doses: Up to 2000 mg daily have been studied safely, though cost becomes prohibitive and additional benefits unclear.
Timing and food: Can be taken with or without food. Some users prefer morning dosing to align with natural circadian NAD+ rhythms, though clinical significance is unknown.
Form considerations: Choose pharmaceutical-grade NR from established manufacturers. Avoid combination products with excessive additional ingredients that dilute the NR content.
Cost
NR is among the most expensive supplements available, costing $70-120 monthly for effective 300-1000 mg daily dosing. The high cost reflects both patent premiums and complex synthesis requirements. Generic alternatives are emerging but quality and potency vary significantly.
The bottom line
Nicotinamide riboside represents the supplement industry's most sophisticated attempt at anti-aging intervention, with solid science showing it effectively raises NAD+ levels as intended. However, you're paying premium prices for biomarker changes whose clinical significance remains unproven. The theory is compelling, the mechanism validated, but functional health benefits await confirmation. Best suited for supplement early-adopters with disposable income who want to experiment with cutting-edge anti-aging compounds. If you want proven benefits rather than promising biomarkers, your money is better spent on established interventions with clinical endpoints.
References
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286.
- Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019;28(7):1717-1728.
- Dellinger RW, Santos SR, Morris M, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. NPJ Aging Mech Dis. 2017;3:17.
Sources for this page include published meta-analyses, systematic reviews, and NIH dietary supplement fact sheets. All claims reflect the evidence as of early 2026.
This is not medical advice. Consult your healthcare provider before starting any supplement, especially if you take medications.